Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€14.66

€14.66

-3.380%
-0.51
-3.380%
€20.00

€20.00

 
19.04.24 / Tradegate WKN: A1W6ND / Symbol: MGNX / Name: MacroGenics / Stock / Biotechnology & Medical Research / Small Cap /
Latest predictions
€20.00
19.04.24
0.41%
buy
09.04.24
-12.27%
buy
€21.20
29.02.24
-11.69%
buy
€20.00
04.02.24
1.81%
buy
17.01.24
48.08%
buy
€11.86
20.12.23
54.32%
buy
Best running prediction
-
02.09.23
218.75%
buy
Your prediction

MacroGenics Inc. Stock

MacroGenics Inc. took a tumble today and lost -€0.510 (-3.380%).
MacroGenics Inc. is currently one of the favorites of our community with 10 Buy predictions and no Sell predictions.
As a result the target price of 20 € shows a positive potential of 36.43% compared to the current price of 14.66 € for MacroGenics Inc..
For the coming years our community has positive and negative things to say abot the MacroGenics Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Valuation (undervalued/overvalued)" there were negative voices in the community.

Pros and Cons of MacroGenics Inc. in the next few years

Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of MacroGenics Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
MacroGenics Inc. -3.380% -6.624% 3.239% 134.560% 62.889% -47.568% -
Ardelyx Inc. 0.130% -5.482% -15.972% 32.578% 3.218% -12.905% -
Salarius Pharmaceuticals Inc. 4.250% -0.935% -18.462% -68.120% -23.604% -98.261% -99.994%
Brainstorm Cell 1.170% -0.896% -1.485% -81.710% 114.440% -80.717% -

Comments

MacroGenics, Inc. (NASDAQ: MGNX) was upgraded by analysts at TD Cowen from a "hold" rating to a "buy" rating.
Ratings data for MGNX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -11.69%
Target price 21.199
Change
Ends at 28.02.25

MacroGenics, Inc. (NASDAQ: MGNX) had its price target raised by analysts at Barclays PLC from $12.00 to $23.00. They now have an "overweight" rating on the stock.
Ratings data for MGNX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 54.32%
Target price 11.857
Change
Ends at 20.12.24

MacroGenics, Inc. (NASDAQ: MGNX) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $13.00 price target on the stock, up previously from $7.00.
Ratings data for MGNX provided by MarketBeat
Show more

News

MacroGenics (MGNX) Q4 2023 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg
MacroGenics (MGNX) Q4 2023 Earnings Call Transcript

Image source: The Motley Fool.

MacroGenics (NASDAQ: MGNX)Q4 2023 Earnings CallMar 07, 2024, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com

MacroGenics (MGNX) Q3 2023 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg
MacroGenics (MGNX) Q3 2023 Earnings Call Transcript

Image source: The Motley Fool.

MacroGenics (NASDAQ: MGNX)Q3 2023 Earnings CallNov 06, 2023, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com